Approval · Notice of Compliance 10175 · 2009
OMNITROPE: Notice of Compliance 10175
Issued April 20, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10175
- Date
- April 20, 2009
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Human growth hormone
Products in this notice
Medicinal ingredients
- SOMATROPIN 5.8 MG per VIAL
- SOMATROPIN 5 MG per 1.5ML
- SOMATROPIN 10 MG per 1.5ML